Postmastectomy chemoradiation therapy(weekly paclitaxel) after adjuvant or neoadjuvant chemothrapy in breast cancer : A phase 1 trial
Phase 1
- Conditions
- breast cancer
- Registration Number
- JPRN-UMIN000001571
- Lead Sponsor
- agoya university hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 12
Inclusion Criteria
Not provided
Exclusion Criteria
This study excludes the patients who are judged as being contrary to every condition of the following conditions by investigators. 1)Severe pleural effusion,pleural effusion or ascites 2)Congestive heart failure, coronary insufficiency, acute myocardial infarction within 6 months 3)Cerebrovascular accident within 6 months 4)Poorly controlled diabetes or treated with insulin 5)Poorly controlled hypertension 6)Active infection 7)Pregnant, lactating, and probably pregnant patients, and patients who want to become pregnant after the study period 8)Psychological distress 9)Other patients judged as being inappropriate for the subjects of the study by attending physician
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The decision of a maximum tolerated dose of weekly paclitaxel with concurrent radiation therapy
- Secondary Outcome Measures
Name Time Method The decisin of a recommended dose of weekly paclitaxel with concurrent radiation therapy and confirmation of adverse reaction